trecadrine has been researched along with Alloxan Diabetes in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrionuevo, M; Cenarruzabeitia, E; Martínez, JA; Milagro, FI | 1 |
| Barber, A; Berraondo, B; Diez-Sampedro, A; Martinez, JA; Milagro, FI; Zulet, MA | 1 |
| Gómez-Ambrosi, J; Martínez, JA; Martínez-Ansó, E; Milagro, FI | 1 |
| Martínez, JA; Milagro, FI | 1 |
| Forga, L; Gómez-Ambrosi, J; Martínez, JA; Milagro, FI | 1 |
5 other study(ies) available for trecadrine and Alloxan Diabetes
| Article | Year |
|---|---|
Potential anti-diabetic applications of a new molecule with affinity for beta 3-adrenoceptors.
Topics: Adipose Tissue; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Benzyl Alcohols; Blood Glucose; Diabetes Mellitus, Experimental; Esophagus; Female; Guinea Pigs; Imidazoles; Insulin; Muscle Relaxation; Muscle, Smooth; Oxygen Consumption; Propanolamines; Rats; Rats, Wistar; Triglycerides | 1996 |
Effects of trecadrine, a beta 3-adrenergic agonist, on intestinal absorption of D-galactose and disaccharidase activities in three physiopathological models.
Topics: Adrenergic beta-Agonists; alpha-Glucosidases; Animals; Benzyl Alcohols; Diabetes Mellitus, Experimental; Disaccharidases; Female; Galactose; Hypercholesterolemia; Intestinal Absorption; Male; Microvilli; Obesity; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3; Sucrase | 1997 |
Effect of a beta3-adrenergic agonist on liver glucokinase gene expression in alloxan-diabetic rats.
Topics: Adrenergic beta-Agonists; Alloxan; Animals; Base Sequence; Benzyl Alcohols; Diabetes Mellitus, Experimental; DNA Primers; Female; Gene Expression Regulation, Enzymologic; Glucokinase; Liver; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3; RNA, Messenger | 1999 |
Effects of the oral administration of a beta3-adrenergic agonist on lipid metabolism in alloxan-diabetic rats.
Topics: Absorption; Administration, Oral; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Animals; Benzyl Alcohols; Body Weight; Carbohydrate Metabolism; Diabetes Mellitus, Experimental; Female; Leptin; Lipid Metabolism; Lipoprotein Lipase; Muscle, Skeletal; Rats; Rats, Wistar | 2000 |
A beta3-adrenergic agonist increases muscle GLUT1/GLUT4 ratio, and regulates liver glucose utilization in diabetic rats.
Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Animals; Benzyl Alcohols; Deoxyglucose; Diabetes Mellitus, Experimental; Female; Gene Expression; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 4; Liver; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 1999 |